Edition:
India

Medivir AB (MVIRb.ST)

MVIRb.ST on Stockholm Stock Exchange

35.65SEK
17 Aug 2018
Change (% chg)

-0.10kr (-0.28%)
Prev Close
35.75kr
Open
35.65kr
Day's High
36.00kr
Day's Low
34.75kr
Volume
29,604
Avg. Vol
45,848
52-wk High
81.75kr
52-wk Low
32.10kr

Chart for

About

Medivir AB is a Sweden-based pharmaceutical company engaged in the research, development and sale of drugs against widespread diseases, with protease and polymerase as its target enzymes. The Company’s research focuses on developing small molecule pharmaceuticals, primarily against infectious diseases caused by viruses. The... (more)

Overall

Beta: 1.15
Market Cap(Mil.): kr1,394.06
Shares Outstanding(Mil.): 19.84
Dividend: --
Yield (%): --

Financials

BRIEF-Medivir Q1 operating loss narrows

* MEDIVIR Q1 NET TURNOVER TOTALED SEK 4.5 MILLION (17.8 M)OF WHICH SEK 4.5 MILLION (13.7 M) COMPRISED THE FIRST QUARTER’S ROYALTIES

27 Apr 2018

Earnings vs. Estimates